Provation has announced the appointment of Dr. Lukasz Kowalczyk as Executive Medical Director, marking a significant step in the company’s mission to lead innovation in healthcare technology through a provider-centric approach. Based in Minneapolis, Provation is elevating its clinical and AI leadership with Dr. Kowalczyk, a nationally recognized gastroenterologist and health tech pioneer, whose expertise spans clinical practice, entrepreneurship, and responsible AI integration. Dr. Kowalczyk joins Provation with a strong foundation in both medicine and digital health innovation. A graduate of the Mayo Clinic AI Accelerator and a member of the HIMSS AI Advisory Group, he is widely acknowledged for advancing ethical and scalable AI adoption in healthcare. His proprietary Clinical Enterprise Value Stack (CEVS) framework will serve as a strategic foundation for Provation’s product development, ensuring solutions deliver measurable improvements in clinical outcomes and operational efficiency. “Provation’s vision centers on designing with empathy, precision, and a deep understanding of provider needs,” said Dr. Kowalczyk. “I’m excited to help shape the future of healthcare technology in a way that truly reflects the realities of clinical practice.” Ankush Kaul, President of Provation, emphasized the strategic importance of the appointment. “We believe that true innovation begins with deep clinical insight and a passion for improving patient outcomes,” Kaul said. “Dr. Kowalczyk embodies this belief, and we are thrilled to welcome him to our team.” With extensive frontline experience as a practicing gastroenterologist and a history of launching successful health tech ventures, Dr. Kowalczyk brings a rare blend of clinical authenticity and technological foresight. His leadership will ensure Provation’s platforms remain tightly aligned with real-world workflows, empowering physicians, hospitals, and health systems with smarter, more intuitive tools. In his new role, Dr. Kowalczyk will represent Provation at major industry events, medical societies, and advisory boards, influencing national and global conversations around clinical quality, interoperability, and the future of procedural care. His insights will directly inform product strategy, helping to align Provation’s innovations with evolving standards and the dynamic needs of healthcare providers. Backed by Fortive and built on more than three decades of enterprise experience, Provation is uniquely positioned to scale impactful solutions across the healthcare continuum. Dr. Kowalczyk’s clinical leadership will be instrumental in transforming Provation’s capabilities into tools that deliver lasting value at the point of care. Provation is a leading provider of software solutions designed to enhance clinical workflows in gastroenterology and anesthesia. Its platforms are trusted by over 5,000 hospitals, surgery centers, and medical offices worldwide. Driven by a purpose-led mission, Provation continues to advance productivity and patient outcomes through intelligent documentation and workflow optimization. For more information, visit provationmedical.com and follow the company on Twitter, Facebook, and LinkedIn.